World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
92
Citations
45180
World Ranking
607
National Ranking
279

Medicine

D-Index
94
Citations
46167
World Ranking
10285
National Ranking
5288

Overview

John H. Rex is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily focuses on fields related to medicine, with a significant body of work in infectious diseases, economics and econometrics, applied microbiology and biotechnology, epidemiology, and pharmacology.

Their publication record includes contributions to multiple prominent venues, highlighting a consistent focus on infectious disease and antimicrobial topics. Frequent publication venues encompass Open Forum Infectious Diseases, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Translational Research, and Nature Reviews Microbiology.

Key topics covered in John H. Rex's research include:

  • Antifungal resistance and susceptibility
  • Antibiotic Use and Resistance
  • Pharmaceutical Economics and Policy
  • Fungal Infections and Studies
  • Antibiotic Resistance in Bacteria
  • Infectious Diseases and Mycology
  • Pharmaceutical industry and healthcare

Among their recent papers, notable titles include:

  • "Critical analysis of antibacterial agents in clinical development" (2020), published in Nature Reviews Microbiology
  • "Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020" (2021), published in Clinical Infectious Diseases
  • "In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis" (2021), published in Antimicrobial Agents and Chemotherapy
  • "Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization" (2020), published in Translational Research
  • "Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?" (2021), published in Value in Health

John H. Rex collaborates frequently with several researchers, including Kevin Outterson, Johan Maertens, Karen Cornelissen, Aaron Dane, and Daniela Zinzi. These coauthors appear repeatedly in multiple research efforts, indicating ongoing scientific partnerships.

Best Publications

  • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

    Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Guidelines for Treatment of Candidiasis

    Peter G. Pappas;John H. Rex;Jack D. Sobel;Scott G. Filler

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • Practice Guidelines for the Treatment of Candidiasis

    John H. Rex;Thomas J. Walsh;Jack D. Sobel;Scott G. Filler

  • A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

    John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas

  • RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE

    J H Rex;M G Rinaldi;M A Pfaller

  • A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

    Peter G. Pappas;John H. Rex;Jeannette Lee;Richard J. Hamill

  • Alternatives to antibiotics—a pipeline portfolio review

    Lloyd Czaplewski;Richard Bax;Martha Clokie;Mike Dawson

  • Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

    Luis Ostrosky-Zeichner;Barbara D. Alexander;Daniel H. Kett;Jose Antonio Vazquez

  • Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials

    David R. Andes;Nasia Safdar;John W. Baddley;Geoffrey Playford

  • β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

    Zekaver Odabasi;Gloria Mattiuzzi;Elihu Estey;Hagop Kantarjian

  • Combating antimicrobial resistance: policy recommendations to save lives.

    Spellberg B;Blaser M;Guidos Rj

  • A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

    John H. Rex;John H. Rex;Peter G. Pappas;Adolf W. Karchmer;Jack Sobel

  • Combination Antifungal Therapy

    Melissa D. Johnson;Conan MacDougall;Luis Ostrosky-Zeichner;John R. Perfect

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

    John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi

  • Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

    B J Kullberg;J D Sobel;M Ruhnke;P G Pappas

  • An insight into the antifungal pipeline: selected new molecules and beyond.

    Luis Ostrosky-Zeichner;Arturo Casadevall;John N. Galgiani;Frank C. Odds

  • Amphotericin B: Time for a New “Gold Standard”

    Luis Ostrosky-Zeichner;Kieren A Marr;John H Rex;John H Rex;Stuart H Cohen

  • Antifungal drug resistance in pathogenic fungi.

    H Vanden Bossche;F Dromer;I Improvisi;M Lozano-Chiu

Frequent Co-Authors

Luis Ostrosky-Zeichner
Luis Ostrosky-Zeichner The University of Texas Health Science Center at Houston
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Jack D. Sobel
Jack D. Sobel Wayne State University
John E. Bennett
John E. Bennett National Institutes of Health
John E. Edwards
John E. Edwards University of California, Los Angeles
Elias Anaissie
Elias Anaissie University of Cincinnati
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Mahmoud A. Ghannoum
Mahmoud A. Ghannoum Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring microbiology, expanding your skill set with complementary healthcare qualifications can open diverse career opportunities. For example, becoming a certified professional coder (cpc) offers a specialized path within medical records and billing, combining technical knowledge with healthcare expertise.

Healthcare organizations increasingly rely on efficient data management, making a role in health information leadership promising. Exploring the healthcare information management salary landscape reveals strong demand and competitive compensation for experts who blend clinical understanding with management skills.

Accredited programs are crucial for credibility and career advancement. Pursuing an accredited online health information management degree cahiim ensures you receive quality education aligned with industry standards, preparing you for certification and leadership roles.

For those seeking quick entry into the field, an online medical billing and coding certificate fast can accelerate your qualification timeline, enabling you to start your career efficiently while building a strong foundation in healthcare administration.

Best Scientists Citing John H. Rex

Trending Scientists